Balandya E, Miller AD, Beck M, Liu J, Li H, Borducchi E, Smith K, Cabral C, Stanley K, Maxfield LF, Barouch DH. Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys. J. Virol. 2014; 88:3756-3765.
Li M, Jurado KA, Lin S, Engelman A, Craigie R. Engineered hyperactive integrase for concerted HIV-1 DNA integration. PLoS One 2014 Aug 13;9(8):e105078. doi: 10.1371/journal.pone.0105078. eCollection 2014. PubMed PMID: 25119883; PubMed Central PMCID: PMC4132020.
Teigler JE, Kagan JC, Barouch DH. Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity. J. Virol. 2014; 88:10354-10363.
Engelman A, Cherepanov P. Spectrum 2014 Dec;2(6):1-22. doi: 10.1128/microbiolspec.MDNA3-0024-2014. PubMed PMID: 25705574; PubMed Central PMCID: PMC4334468.
Scharf L, Scheid JF, Lee JH, West AP Jr, Chen C, Gao H, Gnanapragasam PN, Mares R, Seaman MS, Ward AB, Nussenzweig MC, Bjorkman PJ. Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep. 2014, 7(3):785-95.
Klein F, Nogueira L, Nishimura Y, Phad G, West AP Jr, Halper-Stromberg A, Horwitz JA, Gazumyan A, Liu C, Eisenreich TR, Lehmann C, Fätkenheuer G, Williams C, Shingai M, Martin MA, Bjorkman PJ, Seaman MS, Zolla-Pazner S, Karlsson Hedestam GB, Nussenzweig MC. Enhanced HIV-1 immunotherapy by commonly arising antibodies that target the trimer apex. J. Exp. Med. 2014, 211(12):2361-72.
Li, Q., Duan, S., Zeng, M., Shang, L., Smith, A., Wietgrefe, S., Southern, P. J., Reilly, C. S., Pambuccian, S., Skinner, P. J., Zupancic, M., Piatak, M., Waterman, D., Reeves, R. K., Lifson, J. D., Johnson, R. P., and Haase, A. T. 2014. Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry. J. Immunol. 193(6):3113-25. PMID: 25135832. PMCID: PMC4157131
Li, H., Goepfert, P., and Reeves, R. K. 2014. Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activation. AIDS Res. Hum. Retroviruses. 30(12):1213-1315. PMID: 25387330
Wiehe K, Easterhoff D, Luo K, Nicely NI, Bradley T, Jaeger FH, Dennison SM, Zhang R, Lloyd KE, Stolarchuk C, Parks R, Sutherland LL, Scearce RM, Morris L, Kaewkungwal J, Nitayaphan S, Pittisuttithum P, Rerks-Ngarm S, Sinangil F, Phogat S, Michael NL, Kim JH, Kelsoe G, Montefiori DC, Tomaras GD, Bonsignori M, Santra S, Kepler TB, Alam SM, Moody MA, Liao HX, Hanyes BF. Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved. Immunity 2014; 41:909-918.
Palmer CD, Tomassilli J, Sirignano M, Tejeda MR, Arnold KB, Che D, Lauffenburger DA, Jost S, Allen T, Mayer KH, Altfeld M. Enhanced immune activation linked to endotoxemia in HIV-1 seronegative MSM. (2014) AIDS. 28(14):2162-66.
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]